Company / Current Assets
Moleculin Biotech, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$9.7M
FY2025
5-year range
$5.2M / $72.5M
FY2021-FY2025
Trend
+86.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 3 years of decline, reaching $10M.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of -10.8%.
Declined from $26M to $10M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -40.3%
- 5-Year CAGR
- -10.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -10.8%, indicating a declining trend.
- In FY2025, current assets increased 86.5% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.7M | +86.5% |
| FY2024 | $5.2M | -80.2% |
| FY2023 | $26.3M | -42.4% |
| FY2022 | $45.6M | -37.1% |
| FY2021 | $72.5M | +321.5% |
| FY2020 | $17.2M | +27.5% |
| FY2019 | $13.5M | +69.1% |
| FY2018 | $8.0M | -4.0% |
| FY2017 | $8.3M | +59.0% |
| FY2016 | $5.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026